SKI Market

A+| A| A-|

Indian Indices

Sensex

77,844.52 -114.00
( -0.15%)

Global Indices

Nasdaq

49,922.52 603.26
(1.22%)

Dow Jones

7,387.39 107.17
(1.47%)

Hang Seng

62,916.52 3,403.40
(5.72%)

Nikkei 225

10,442.09 222.98
(2.18%)

Forex

USD-INR

95.18 0.09
(0.09%)

EUR-INR

111.29 -0.04
(-0.04%)

GBP-INR

128.89 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

23.57

109381.8

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.61

Back

Ajooni Biotech standalone net profit rises 50.00% in the September 2025 quarter

Nov 13,2025

Net profit of Ajooni Biotech rose 50.00% to Rs 0.93 crore in the quarter ended September 2025 as against Rs 0.62 crore during the previous quarter ended September 2024. Sales rose 23.41% to Rs 31.74 crore in the quarter ended September 2025 as against Rs 25.72 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	31.74	25.72	23
OPM %	4.73	3.03	-
PBDT	1.48	1.03	44
PBT	1.23	0.80	54
NP	0.93	0.62	50

77,844.52 -114.00 ( -0.15%)

49,922.52 603.26 (1.22%)

7,387.39 107.17 (1.47%)

62,916.52 3,403.40 (5.72%)

10,442.09 222.98 (2.18%)

95.18 0.09 (0.09%)

111.29 -0.04 (-0.04%)

128.89 -0.01 (-0.01%)

0.60 0.00 (-0.23%)